These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3181485

  • 1. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
    Li TC, Dockery P, Thomas P, Rogers AW, Lenton EA, Cooke ID.
    Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
    [Abstract] [Full Text] [Related]

  • 2. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 3. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE, Kettel LM, Yen SS.
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [Abstract] [Full Text] [Related]

  • 4. The use of anti-progesterones as a medical IUD.
    Nieman LK, Loriaux DL.
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [Abstract] [Full Text] [Related]

  • 5. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
    Li TC, Lenton EA, Dockery P, Rogers AW, Cooke ID.
    Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
    [Abstract] [Full Text] [Related]

  • 6. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 7. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 8. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 9. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [Abstract] [Full Text] [Related]

  • 10. The effects of the antiprogesterone RU486 (Mifepristone) on an endometrial secretory glycan: an immunocytochemical study.
    Graham RA, Li TC, Seif MW, Aplin JD, Cooke ID.
    Fertil Steril; 1991 Jun; 55(6):1132-6. PubMed ID: 1709886
    [Abstract] [Full Text] [Related]

  • 11. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K, Svalander P, Swahn ML, Johannisson E, Bygdeman M.
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [Abstract] [Full Text] [Related]

  • 12. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

  • 13. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB, Salvatierra AM, Croxatto HD, Spitz IM.
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [Abstract] [Full Text] [Related]

  • 14. Luteal contraception.
    Yen S, Garzo G, Liu J.
    Contraception; 1987 Jul; 36 Suppl():13-25. PubMed ID: 2824125
    [Abstract] [Full Text] [Related]

  • 15. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 17. Late luteal administration of the antiprogesterone RU486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study.
    Couzinet B, Le Strat N, Silvestre L, Schaison G.
    Fertil Steril; 1990 Dec; 54(6):1039-44. PubMed ID: 2245828
    [Abstract] [Full Text] [Related]

  • 18. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 19. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.
    Dockery P, Ismail RM, Li TC, Warren MA, Cooke ID.
    Hum Reprod; 1997 Aug; 12(8):1778-84. PubMed ID: 9308811
    [Abstract] [Full Text] [Related]

  • 20. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.